Biomed Central accepting case reports … again

“Following the recent departure of the Journal of Medical Case Reports from BioMed Central’s portfolio, the medical journals in the BMC series have started considering case reports again.” http://blogs.openaccesscentral.com/blogs/bmcblog/entry/submit_your_next_case_report1 It seems that case reports are among the most popular pages on the open-access journals website. This renaissance in publishing (and reading) case reports is very […]

Read More…

Lantus rumours, share prices and IGF-1

Sanofi-aventis’s share price has been affected by rumours of a cancer risk with their insulin analogue Lantus. http://uk.reuters.com/article/idUKLP34230220090625 The source of the rumour and whether it consists of case reports, population studies, or further in-vitro work is not known but there have been concerns about glargine before. It appears to stimulate IGF-1 receptors more than […]

Read More…